Results 61 to 70 of about 651,421 (240)
The SGOT/SGPT ratio in alcoholic liver disease.
Acta Médica Portuguesa, 1981 The SGOT/SGPT ratio has been estimated in 207 patients with alcoholic liver disease and in 3 control groups (43 viral hepatitis, 30 non-alcoholic chronic liver disease and 42 obstructive jaundice).
Patrícia S. Alves +2 more
doaj +1 more source
Medical Clinics of North America, 1989 Alcohol has been implicated in the genesis of liver disease for centuries. Significant progress has been made in our understanding of the pathogenesis of ALD. It is now apparent that both the consumption and the metabolism of alcohol promote the production of inflammatory mediators (cytokines) that result in hepatotoxicity and fibrogenesis.
openaire +3 more sources
Cell Death in Liver Diseases: A Review
International Journal of Molecular Sciences, 2020 Regulated cell death (RCD) is pivotal in directing the severity and outcome of liver injury. Hepatocyte cell death is a critical event in the progression of liver disease due to resultant inflammation leading to fibrosis. Apoptosis, necrosis, necroptosis,
Layla Shojaie, Andrea Iorga, Lily Dara
semanticscholar +1 more source
Bifidobacteria and lactobacilli in the gut microbiome of children with non-alcoholic fatty liver disease: which strains act as health players? [PDF]
, 2018 Introduction: Non-alcoholic fatty liver disease (NAFLD), considered the leading cause of chronic liver disease in children, can often progress from non-alcoholic fatty liver (NAFL) to non-alcoholic steatohepatitis (NASH).
Alisi, A +9 more
core +3 more sources
Bile Acids and FXR: Novel Targets for Liver Diseases
Frontiers in Medicine, 2020 Bile acids (BAs) are evolutionally conserved molecules synthesized in the liver from cholesterol and have been shown to be essential for lipid homeostasis.
Mary Stofan, G. Guo
semanticscholar +1 more source
Clinico-Biochemical Correlation to Histological Findings in Alcoholic Liver Disease: A Single Centre Study from Eastern India [PDF]
Journal of Clinical and Diagnostic Research, 2014 Background: Alcoholism is a health problem not only in developed countries but also in developing countries. Cirrhosis due to alcohol is a common cause of death among individuals abusing alcohol.
Sayantan Ray +7 more
doaj +1 more source
Drugs in Context, 2023 Non-alcoholic fatty liver disease is one of the main causes of elevated liver enzymes and chronic liver disease worldwide. It ranges from steatosis to steatohepatitis, leading to cirrhosis and related liver dysfunction.
Yeong Yeh Lee, Vincent Tee
doaj +1 more source
Immunological mechanisms and therapeutic targets of fatty liver diseases
Cellular & Molecular Immunology, 2020 Alcoholic liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD) are the two major types of chronic liver disease worldwide. Inflammatory processes play key roles in the pathogeneses of fatty liver diseases, and continuous inflammation promotes
Hua Wang, W. Mehal, L. Nagy, Y. Rotman
semanticscholar +1 more source
Gut microbiome changes in Nonalcoholic fatty liver disease & alcoholic liver disease.
Translational Gastroenterology and Hepatology, 2021 Nonalcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD) are some of the most common liver diseases worldwide. The human gut microbiome is dynamic and shifts in bacterial composition have been implicated in many diseases.
Eric K. Kwong, P. Puri
semanticscholar +1 more source
Рациональная фармакотерапия в кардиологии, 2022 The association of non-alcoholic fatty liver disease (NAFLD) and cardiovascular risk is currently one of the actively studied areas. The incidence of non-alcoholic fatty liver disease continues to grow worldwide.
A. V. Nelidova +3 more
doaj +1 more source